Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
The Pulse by Wharton Digital Health - Belinda Tan & Noah Craft, People Science, on enabling human-centered and clinically-rigorous testing for alternative medicines

Belinda Tan & Noah Craft, People Science, on enabling human-centered and clinically-rigorous testing for alternative medicines

10/24/23 • 44 min

The Pulse by Wharton Digital Health

In this episode, I sat down with Belinda Tan and Noah Craft, Co-Founders and Co-CEOs at People Science. Founded in 2019, People Science is a human-centered clinical research platform addressing the need for rigorous clinical science to back alternative medicines and wellness solutions that do not typically fall under traditional Western medicine. The company’s platform studies a range of solutions spanning microbiome and food-as-medicine interventions, natural and synthetic psychedelic medicines, cannabis and cannabinoids, functional medicines, and digital therapeutics. Its user-facing app called Chloe (Consumer Health Learning and Organizing Ecosystem) supports users to test these alternative treatments on themselves, and enables users to view personal results in real time while comparing themselves to others. People Science secured its $8.5 million seed funding through two rounds, most recently in December 2022.

Belinda, Noah and I discussed: 1) Their founding story and unique co-CEO leadership model, 2) The philosophy behind the People Science platform, including the nuances of alternative medicines compared to traditional Western medicine, 3) The business model, including both how studies are launched with B2B partners and the consumer-facing app (Chloe), and 4) Insights and advice from having co-founded and co-led not one, but two, companies together.

plus icon
bookmark

In this episode, I sat down with Belinda Tan and Noah Craft, Co-Founders and Co-CEOs at People Science. Founded in 2019, People Science is a human-centered clinical research platform addressing the need for rigorous clinical science to back alternative medicines and wellness solutions that do not typically fall under traditional Western medicine. The company’s platform studies a range of solutions spanning microbiome and food-as-medicine interventions, natural and synthetic psychedelic medicines, cannabis and cannabinoids, functional medicines, and digital therapeutics. Its user-facing app called Chloe (Consumer Health Learning and Organizing Ecosystem) supports users to test these alternative treatments on themselves, and enables users to view personal results in real time while comparing themselves to others. People Science secured its $8.5 million seed funding through two rounds, most recently in December 2022.

Belinda, Noah and I discussed: 1) Their founding story and unique co-CEO leadership model, 2) The philosophy behind the People Science platform, including the nuances of alternative medicines compared to traditional Western medicine, 3) The business model, including both how studies are launched with B2B partners and the consumer-facing app (Chloe), and 4) Insights and advice from having co-founded and co-led not one, but two, companies together.

Previous Episode

undefined - Todd Park, Devoted Health, on building the "American healthcare system as a service"

Todd Park, Devoted Health, on building the "American healthcare system as a service"

Our guest on this episode is Todd Park. Todd is the co-founder and Executive Chairman of Devoted Health, a Medicare Advantage “payvider” providing virtual and in-home medical care for older Americans and leveraging their technology platform to drive clinical results. Founded in 2017, Devoted’s team of over 2,000 cares for nearly 124,000 members across 14 states. Todd previously served as the White House Technology Advisor and the HHS Chief Technology Officer in the Obama Administration, and was the co-founder of athenahealth and Castlight.

In this episode, I spoke with Todd about

  • His entrepreneurial journey
  • His time in the White House
  • Why Devoted is situated to transform the healthcare experience for older Americans

Next Episode

undefined - Siva Namasivayam, Cohere Health, on transforming prior authorization into a quality improvement process

Siva Namasivayam, Cohere Health, on transforming prior authorization into a quality improvement process

Siva Namasivayam is the co-founder and CEO of Cohere Health, an AI-powered platform that simplifies the time-consuming prior authorization process for health plans & providers. In this episode, Siva and I discussed his path to entrepreneurship, responsible use of AI in utilization management, how Cohere is transforming prior authorization from an administrative burden into a quality improvement process.

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/the-pulse-by-wharton-digital-health-264609/belinda-tan-and-noah-craft-people-science-on-enabling-human-centered-a-35430943"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to belinda tan & noah craft, people science, on enabling human-centered and clinically-rigorous testing for alternative medicines on goodpods" style="width: 225px" /> </a>

Copy